Publications by authors named "P Pieragnoli"
Background: In patients with Hypertrophic Cardiomyopathy (HCM) S-ICD is usually the preferred option as pacing is generally not indicated. However, limited data are available on its current practice adoption and long-term follow-up.
Methods: Consecutive HCM patients with S-ICD implanted between 2013 and 2021 in 3 international centers were enrolled in this observational study.
Article Synopsis
- HFpEF is a complex condition influenced by factors like age, genetics, and various health issues, including kidney disease, which significantly affects its progression and management.
- The relationship between heart failure (HF) and chronic kidney disease (CKD) is intricate, as both share similar biological pathways and pose challenges for effective treatment due to patients often not being well-represented in clinical trials.
- Newer medications, particularly SGLT2 inhibitors, show promise for treating patients with both HFpEF and CKD, highlighting the importance of understanding their cardiorenal interactions for improved management strategies.
We report a case of successful implantation of a subcutaneous implantable cardioverter-defibrillator in a young patient with severe pectus excavatum presenting with out-of-hospital ventricular fibrillation arrest who was recently surgically repaired with a MIRPE-Nuss procedure. No complications in lead positioning were observed, and the device was tested to determine that it functioned properly.
View Article and Find Full Text PDFArtificial Intelligence (AI) applications and Machine Learning (ML) methods have gained much attention in recent years for their ability to automatically detect patterns in data without being explicitly taught rules. Specific features characterise the ECGs of patients with Brugada Syndrome (BrS); however, there is still ambiguity regarding the correct diagnosis of BrS and its differentiation from other pathologies. This work presents an application of Echo State Networks (ESN) in the Recurrent Neural Networks (RNN) class for diagnosing BrS from the ECG time series.
View Article and Find Full Text PDFAims: The implantable cardioverter-defibrillator (ICD) is a life-saving therapy in patients with hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death. Implantable cardioverter-defibrillator complications are of concern. The subcutaneous ICD (S-ICD) does not use transvenous leads and is expected to reduce complications.
View Article and Find Full Text PDF